Techniques that block MSI2 or restore Numb expression may encourage leukemia cell differentiation, decrease the number of leukemia stem cells, and increase the efficacy of currently used therapies such tyrosine kinase inhibitors (Moradi et al., 2019; Ito et al., 2010; Pereira et al., 2012). This evidence concerns the gene NUMB and leukemia.